These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28738683)

  • 21. Prescription drug monitoring and drug overdose mortality.
    Li G; Brady JE; Lang BH; Giglio J; Wunsch H; DiMaggio C
    Inj Epidemiol; 2014 Dec; 1(1):9. PubMed ID: 27747666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences.
    Kim B
    J Health Econ; 2021 Jan; 75():102408. PubMed ID: 33316762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data.
    Nechuta SJ; Tyndall BD; Mukhopadhyay S; McPheeters ML
    Drug Alcohol Depend; 2018 Sep; 190():62-71. PubMed ID: 29981943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.
    Henry SG; Shev AB; Crow D; Stewart SL; Wintemute GJ; Fenlon C; Wirtz SJ
    Prev Med; 2021 Dec; 153():106861. PubMed ID: 34687731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.
    Rhodes E; Wilson M; Robinson A; Hayden JA; Asbridge M
    BMC Health Serv Res; 2019 Nov; 19(1):784. PubMed ID: 31675963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do prescription drug monitoring programs encourage prescription - or illicit - opioid abuse?
    Meadowcroft D; Whitacre B
    Subst Abus; 2021; 42(1):65-75. PubMed ID: 31821128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
    Rudd RA; Aleshire N; Zibbell JE; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription drug monitoring programs and death rates from drug overdose.
    Paulozzi LJ; Kilbourne EM; Desai HA
    Pain Med; 2011 May; 12(5):747-54. PubMed ID: 21332934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National trends and outcomes of cardiac arrest in opioid overdose.
    Sakhuja A; Sztajnkrycer M; Vallabhajosyula S; Cheungpasitporn W; Patch R; Jentzer J
    Resuscitation; 2017 Dec; 121():84-89. PubMed ID: 29037885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States.
    Puac-Polanco V; Chihuri S; Fink DS; Cerdá M; Keyes KM; Li G
    Epidemiol Rev; 2020 Jan; 42(1):134-153. PubMed ID: 32242239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the impact of prescription drug monitoring program implementation: a scoping review.
    Finley EP; Garcia A; Rosen K; McGeary D; Pugh MJ; Potter JS
    BMC Health Serv Res; 2017 Jun; 17(1):420. PubMed ID: 28633638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between State Policies on Improving Opioid Prescribing in 2 States and Opioid Overdose Rates Among Reproductive-aged Women.
    Ji X; Haight SC; Ko JY; Cox S; Barfield WD; Zhang K; Guy GP; Li R
    Med Care; 2021 Feb; 59(2):185-192. PubMed ID: 33273289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of a Predictive Model versus Prescription-Based Thresholds in Identifying Patients at Risk of Fatal Opioid Overdose.
    Ferris LM; Saloner B; Jackson K; Lyons BC; Murthy V; Kharrazi H; Latimore A; Stuart EA; Weiner JP
    Subst Use Misuse; 2021; 56(3):396-403. PubMed ID: 33446000
    [No Abstract]   [Full Text] [Related]  

  • 35. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.
    Ali MM; Dowd WN; Classen T; Mutter R; Novak SP
    Addict Behav; 2017 Jun; 69():65-77. PubMed ID: 28152391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using statewide death certificate data to understand trends and characteristics of polydrug overdose deaths in Tennessee, 2013-2017.
    Golladay M; Donner K; Nechuta S
    Ann Epidemiol; 2020 Jan; 41():43-48.e1. PubMed ID: 31928897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From the CDC: The Prevention for States program: Preventing opioid overdose through evidence-based intervention and innovation.
    Robinson A; Christensen A; Bacon S
    J Safety Res; 2019 Feb; 68():231-237. PubMed ID: 30876516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone related deaths compared to all prescription related deaths.
    Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
    Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug monitoring programs evaluation: A systematic review of reviews.
    Tay E; Makeham M; Laba TL; Baysari M
    Drug Alcohol Depend; 2023 Jun; 247():109887. PubMed ID: 37126936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.